Clinical trials
Completed Observational Precancerous Conditions trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AIDS Malignancy Consortium | 3 |
| Integrated Diagnostics | 2 |
| National Cancer Institute (NCI) | 2 |
| SWOG Cancer Research Network | 2 |
| Albert Einstein College of Medicine | 1 |
| Atossa Therapeutics, Inc. | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Barts and the London School of Medicine and Dentistry | 1 |
| British Columbia Cancer Agency | 1 |
| Cairo University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precancerous Conditions | 31 |
| Papillomavirus Infections | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Intraductal, Noninfiltrating | 3 |
| Colonic Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| HIV Infections | 3 |
| Lung Neoplasms | 3 |
| Monoclonal Gammopathy of Undetermined Significance | 3 |
| Rectal Neoplasms | 3 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.